New Insights in the Amyloid-Beta Interaction with Mitochondria
Open Access
- 19 March 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Aging Research
- Vol. 2012, 1-9
- https://doi.org/10.1155/2012/324968
Abstract
Biochemical and morphological alterations of mitochondria may play an important role in the pathogenesis of Alzheimer’s disease (AD). Particularly, mitochondrial dysfunction is a hallmark of amyloid-beta-induced neuronal toxicity in Alzheimer’s disease. The recent emphasis on the intracellular biology of amyloid-beta and its precursor protein (APP) has led researchers to consider the possibility that mitochondria-associated and mitochondrial amyloid-beta may directly cause neurotoxicity. Both proteins are known to localize to mitochondrial membranes, block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins, disrupt the electron transport chain, increase reactive oxygen species production, cause mitochondrial damage, and prevent neurons from functioning normally. In this paper, we will outline current knowledge of the intracellular localization of amyloid-beta. Moreover, we summarize evidence from AD postmortem brain as well as animal AD models showing that amyloid-beta triggers mitochondrial dysfunction through a number of pathways such as impairment of oxidative phosphorylation, elevation of reactive oxygen species production, alteration of mitochondrial dynamics, and interaction with mitochondrial proteins. Thus, this paper supports the Alzheimer cascade mitochondrial hypothesis such as the most important early events in this disease, and probably one of the future strategies on the therapy of this neurodegenerative disease.Keywords
This publication has 81 references indexed in Scilit:
- Modes of Aβ toxicity in Alzheimer’s diseaseCellular and Molecular Life Sciences, 2011
- Mitochondria: The Next (Neurode)GenerationNeuron, 2011
- Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse modelNeurobiology of Aging, 2011
- Mitochondrial medicine for neurodegenerative diseasesThe International Journal of Biochemistry & Cell Biology, 2010
- Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's diseaseNature Medicine, 2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004